We are live on ! Find out more
ABBV icon

AbbVie
ABBV

1,423 hedge funds and large institutions have $56.7B invested in AbbVie in 2014 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 493 increasing their positions, 656 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more call options, than puts

Call options by funds: $323M | Put options by funds: $156M

7% more first-time investments, than exits

New positions opened: 72 | Existing positions closed: 67

0.09% less ownership

Funds ownership: 69.06% → 68.97% (-0.09%)

1% less funds holding

Funds holding: 1,434 → 1,423 (-11)

3% less capital invested

Capital invested by funds: $58.2B → $56.7B (-$1.49B)

14% less funds holding in top 10

Funds holding in top 10: 59 → 51 (-8)

25% less repeat investments, than reductions

Existing positions increased: 493 | Existing positions reduced: 656

Holders
1,423
Holders Change
-11
Holders Change %
-0.77%
% of All Funds
41.09%
Holding in Top 10
51
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-13.56%
% of All Funds
1.47%
New
72
Increased
493
Reduced
656
Closed
67
Calls
$323M
Puts
$156M
Net Calls
+$167M
Net Calls Change
-$33M

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$177M
2
Wells Fargo
Wells Fargo
California
+$118M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$114M
4
FAM
Fred Alger Management
New York
+$105M
5
HCM
Highline Capital Management
New York
+$103M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$249M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$210M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$199M
4
State Street
State Street
Massachusetts
-$197M
5
Lazard Asset Management
Lazard Asset Management
New York
-$151M
Name Holding Trade Value Shares
Change 		Change in
Stake
DAC
1476
Dividend Assets Capital
South Carolina
– -$200K -3,788 Closed
MIS
1477
Morningstar Investment Services
Illinois
– -$200K -3,785 Closed
NC
1478
NewSquare Capital
Pennsylvania
– -$189K -3,576 Closed
JT
1479
Jump Trading
Illinois
– -$187K -3,538 Closed
TT
1480
Tiedemann Trust
Delaware
– -$256K -2,691 Closed
WCM
1481
Windsor Capital Management
Arizona
– -$104K -1,978 Closed
FA
1482
Financial Advantage
Maryland
– -$63K -1,200 Closed
CCM
1483
Chilton Capital Management
Texas
– -$58K -1,098 Closed
FMA
1484
FNY Managed Accounts
New York
– -$53K -1,000 Closed
SHWM
1485
Smith & Howard Wealth Management
Georgia
– -$37K -704 Closed
WCM
1486
Westend Capital Management
California
– -$18K -350 Closed
BWFA
1487
Baltimore-Washington Financial Advisors
Maryland
– -$11K -200 Closed
BCI
1488
Brinker Capital Investments
Pennsylvania
– -$5K -100 Closed
CL
1489
CFS LLC
Oklahoma
– -$5K -100 Closed
EU
1490
Emory University
Georgia
– -$3K -58 Closed
WCM
1491
Wealthcare Capital Management
Virginia
– -$2K -37 Closed
56 57 58 59
60

ABBV Hedge Fund Activity: Q1 2014 in Review

1,423 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q1 2014, worth a combined $56.7B — down 2.6% from $58.2B a quarter earlier.

Buyers outnumbered sellers: 72 funds opened new ABBV positions and 67 closed out — a net gain of 5 holders — while 493 added to existing stakes and 656 trimmed.

The largest buyer was Capital International Investors, adding an estimated $177M. The largest seller was T. Rowe Price Associates, cutting an estimated $249M.

  • 1,423 institutional investors held AbbVie (ABBV) as of Q1 2014, down from 1,434 in Q4 2013.
  • Funds reported $56.7B of AbbVie stock for Q1 2014, down 2.6% quarter-over-quarter.
  • 72 funds opened new AbbVie positions in Q1 2014 and 67 closed out, a net change of +5 holders.
  • The largest AbbVie buyer in Q1 2014 was Capital International Investors, an estimated $177M added.
  • The largest AbbVie seller in Q1 2014 was T. Rowe Price Associates, an estimated $249M sold.

Based on aggregated 13F filings for Q1 2014.